Clinuvel Pharmaceuticals Limited (CUVL)
Nasdaq: CUVL · American Depositary Receipts · filing with the SEC since 2004
The company now
Clinuvel Pharmaceuticals Limited is classed by the SEC under American Depositary Receipts (industry code 8880). In its latest annual figures on file, for the fiscal year ended 2026-06-30, it reported revenue of $64 million and a profit of $23 million (its filed statements).
From its filings and filed figures; the desk's account of it is not written yet.
The desk's written account, its read of the annual report, the record in brief and the split of the revenue are not on file for this company yet.